Literature DB >> 19553306

T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.

Angela Wahl1, William McCoy, Fredda Schafer, Wilfried Bardet, Rico Buchli, Daved H Fremont, William H Hildebrand.   

Abstract

To escape immune recognition, viruses acquire amino acid substitutions in class I human leukocyte antigen (HLA)-presented cytotoxic T-lymphocyte (CTL) epitopes. Such viral escape mutations may (i) prevent peptide processing, (ii) diminish class I HLA binding, or (iii) alter T-cell recognition. Because residues 418 to 426 of the hypervariable influenza A virus nucleoprotein (NP(418-426)) epitope are consistently bound by class I HLA and presented to CTL, we assessed the impact that intraepitope sequence variability has upon T-cell recognition. CTL elicited by intranasal influenza virus infection were tested for their cross-recognition of 20 natural NP(418-426) epitope variants. Six of the variant epitopes, of both H1N1 and H3N2 origin, were cross-recognized by CTL while the remaining NP(418-426) epitope variants escaped targeting. A pattern emerged whereby variability at position 5 (P5) within the epitope reduced T-cell recognition, changes at P4 or P6 enabled CTL escape, and a mutation at P8 enhanced T-cell recognition. These data demonstrate that substitutions at P4 and/or P6 facilitate influenza virus escape from T-cell recognition and provide a model for the number, nature, and location of viral mutations that influence T-cell cross-recognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553306      PMCID: PMC2738244          DOI: 10.1128/JVI.00932-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.

Authors:  J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

3.  Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.

Authors:  N J Beekman; P A van Veelen; T van Hall; A Neisig; A Sijts; M Camps; P M Kloetzel; J J Neefjes; C J Melief; F Ossendorp
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

4.  Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope.

Authors:  H Soudeyns; S Paolucci; C Chappey; M B Daucher; C Graziosi; M Vaccarezza; O J Cohen; A S Fauci; G Pantaleo
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

5.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.

Authors:  Ian A York; Shih-Chung Chang; Tomo Saric; Jennifer A Keys; Janice M Favreau; Alfred L Goldberg; Kenneth L Rock
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

Review 7.  From genome to vaccine: in silico predictions, ex vivo verification.

Authors:  A S De Groot; A Bosma; N Chinai; J Frost; B M Jesdale; M A Gonzalez; W Martin; C Saint-Aubin
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

8.  Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus.

Authors:  P Höllsberg
Journal:  Scand J Immunol       Date:  2002-02       Impact factor: 3.487

9.  Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  HLA class I molecules consistently present internal influenza epitopes.

Authors:  Angela Wahl; Fredda Schafer; Wilfried Bardet; Rico Buchli; Gillian M Air; William H Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

View more
  14 in total

1.  Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.

Authors:  Bin Zhou; Yan Li; Scott D Speer; Anju Subba; Xudong Lin; David E Wentworth
Journal:  Vaccine       Date:  2012-03-24       Impact factor: 3.641

2.  Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.

Authors:  Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 3.  Immunity to seasonal and pandemic influenza A viruses.

Authors:  Sophie A Valkenburg; John A Rutigliano; Ali H Ellebedy; Peter C Doherty; Paul G Thomas; Katherine Kedzierska
Journal:  Microbes Infect       Date:  2011-02-02       Impact factor: 2.700

4.  Preemptive priming readily overcomes structure-based mechanisms of virus escape.

Authors:  Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Lauren A Hatton; Nicola A Bird; Kelly-Anne Twist; Hanim Halim; David C Jackson; Anthony W Purcell; Stephen J Turner; Peter C Doherty; Jamie Rossjohn; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

5.  The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly.

Authors:  Ta-Chien Chan; Chuhsing Kate Hsiao; Chang-Chun Lee; Po-Huang Chiang; Chuan-Liang Kao; Chung-Ming Liu; Chwan-Chuen King
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

6.  HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.

Authors:  Tomer Hertz; Christine M Oshansky; Philippa L Roddam; John P DeVincenzo; Miguela A Caniza; Nebojsa Jojic; Simon Mallal; Elizabeth Phillips; Ian James; M Elizabeth Halloran; Paul G Thomas; Lawrence Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

7.  Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.

Authors:  Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-31       Impact factor: 11.205

8.  Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.

Authors:  Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Nicole L La Gruta; Paul G Thomas; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

9.  Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection.

Authors:  Xichao Guo; Yu Chen; Xuefen Li; Haishen Kong; Shigui Yang; Bo Ye; Dawei Cui; Wei Wu; Lanjuan Li
Journal:  Virol J       Date:  2011-05-10       Impact factor: 4.099

10.  Molecular docking analysis of 2009-H1N1 and 2004-H5N1 influenza virus HLA-B*4405-restricted HA epitope candidates: implications for TCR cross-recognition and vaccine development.

Authors:  Chinh T T Su; Christian Schönbach; Chee-Keong Kwoh
Journal:  BMC Bioinformatics       Date:  2013-01-21       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.